Source: Eur Respir J, 56 (2) 2002328; 10.1183/13993003.02328-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Marina Tadolini, José-María García-García, François-Xavier Blanc, Sergey Borisov, Delia Goletti, Ilaria Motta, Luigi Ruffo Codecasa, Simon Tiberi, Giovanni Sotgiu, Giovanni Battista Migliori. On tuberculosis and COVID-19 co-infection. Eur Respir J, 56 (2) 2002328; 10.1183/13993003.02328-2020

Member's Comments

No comment yet.

Related content which might interest you: The (in)significance of TB and COVID-19 co-infection Source: Eur Respir J, 56 (2) 2002105; 10.1183/13993003.02105-2020 Year: 2020 Mycobacterium tuberculosis bacteremia in reactivation tuberculosis patients without human immunodeficiency virus infection Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005 Co-infection of pulmonary tuberculosis and Covid-19 Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 Influence of HIV infection on spectrum of extrapulmonary tuberculosis Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 Multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in Romania Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine. Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018 TB in migrants Source: Eur Respir Mon 2012; 58: 194-205 Year: 2012 Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients Source: Eur Respir J, 55 (6) 1902383; 10.1183/13993003.02383-2019 Year: 2020 Nontuberculous mycobacterial co-infection in HIV-negative patients with pulmonary tuberculosis Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Particularities of tuberculosis at children hospitalized with HIV co-infection Source: Annual Congress 2009 - Tuberculosis at different age groups Year: 2009 Latent tuberculosis infection as a cause of tuberculosis disease Source: Eur Respir J 2003; 22: Suppl. 45, 157s Year: 2003 Immunological differences between lung tuberculosis and latent tuberculosis infection Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Hair-analysis for acetyl-isoniazid/isoniazid ratio and N-acetyl-transferase-2-genotype in patients on treatment for mycobacterium tuberculosis infection Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011 The impact of HIV on tuberculosis recrudescence Source: Eur Respir J 2004; 24: Suppl. 48, 362s Year: 2004 HIV and multidrug-resistant tuberculosis: overlapping epidemics Source: Eur Respir J 2014; 44: 251-254 Year: 2014 Prevalence of HIV infection among tuberculosis cases and pattern of tuberculosis and treatment outcome in HIV seropositives – a study from a tuberculosis center from India Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 The risk of latent Mycobacterium tuberculosis infection in HIV seropositive children not BCG vaccinated Source: Eur Respir J 2005; 26: Suppl. 49, 424s Year: 2005 Diagnosis of latent tuberculosis infection Source: ERS Live 2007 Year: 2007 Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012